ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 4.
Morgan, Robert D., Porter, Catharine  ORCID: https://orcid.org/0000-0003-1851-0677, Zhou, Cong, Kristeleit, Rebecca, Desai, Sudha, White, Ann, Casbard, Angela C. ORCID: https://orcid.org/0000-0001-6241-3052, Humphrys, Alys, Swettenham, Jennifer B., Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Brogden, Elena, Powell, Wendy E. ORCID: https://orcid.org/0000-0002-4670-1406, Canham, Joanna ORCID: https://orcid.org/0000-0003-3482-0990 and Carucci, Margherita
2026.
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.
EClinicalMedicine
96
, 104012.
10.1016/j.eclinm.2026.104012
|
|
Wallis, L., Wade, J., Farrar, N., Rooshenas, L., Conefrey, C., Mills, N., Shepherd, V. ORCID: https://orcid.org/0000-0002-7687-0817, Nixon, L.S. ORCID: https://orcid.org/0000-0002-1270-6970, Carucci, M., White, A., Harwood, C.A. and Rembielak, A.
2026.
The QuinteT recruitment intervention and its role in oncology randomised controlled trials [Editorial].
Clinical Oncology
49
, 103976.
10.1016/j.clon.2025.103976
|
|
|
|
Murphy, Alexander D, Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, White, Ann, Irving, Alys, Adams, Richard ORCID: https://orcid.org/0000-0003-3915-7243, Ray, Ruby, Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052, Mahmood, Reem D., Karanth, Suman, Zhou, Cong, Pugh, Julia, Wheeler, Chelsey, Roberts, Victoria, Arnetoli, Giorgio, Salih, Zena, Hasan, Jurjees, Mitchell, Claire, Morgan, Robert D., Clamp, Andrew R. and Jayson, Gordon C.
2024.
Once daily cediranib and weekly paclitaxel to prevent malignant bowel obstruction in at-risk patients with platinum-resistant ovarian cancer (CEBOC): a single-arm, phase II safety trial.
International Journal of Gynecological Cancer
34
, pp. 1034-1040.
10.1136/ijgc-2024-005455
|
|
|
|
Fennell, Dean A., Porter, Catharine ORCID: https://orcid.org/0000-0003-1851-0677, Lester, Jason, Danson, Sarah, Blackhall, Fiona, Nicolson, Marianne, Nixon, Lisette ORCID: https://orcid.org/0000-0002-1270-6970, Gardner, Georgina, White, Ann, Griffiths, Gareth and Casbard, Angela ORCID: https://orcid.org/0000-0001-6241-3052
2022.
Olaparib maintenance versus placebo monotherapy in patients with advanced non-small cell lung cancer (PIN): A multicentre, randomised, controlled, phase 2 trial.
EClinicalMedicine
52
, 101595.
10.1016/j.eclinm.2022.101595
|
|
|